Investment Opportunities in UK for 2011-2012
Filed under: Biotech & Pharma, Capital Markets, Commodities, Crude Oil, Financial Services, Healthcare, Industrial Goods, Investment Opportunities, Natural Gas, Real Estate, Recommended, Renewable Energy
Hello Folks, since Jan 2011, we have been researching a few good Investment Opportunities in UK that can be used by investors and entrepreurs in our network – anyone based in the UK or abroad – location does not matter in such investments.
Our focus has been to look at businesses that are net exporters to the world, and have solid assets that will appreciate with time, even if the current economic weakness drags on for 1-2 years more. For some reason, many people in the UK automatically associate investment opportunities with property investments in the UK, but it does not have be like that because by investing in UK property, you are missing out on the growth happening in emerging economies like Brazil, Russia, India and China.
Many UK companies have business interests in these growth economies, and you must profit from them. Given the QE2 and overall positive liquidity in the global capital system, we believe natural resources are present a strong investment opportunity for anyone with 4 to 5 year timeframe.
Within the UK, Internet services, financial services, renewable energy, and pharma/biotech industries also present great investment opportunties that could give 25-50% return on investment in 2011-2012 timeframe. If you are interested to know more, please contact us .
Business Leads Generation Service
Filed under: Business-Services, Commodities, Consumer Goods, E-Business, Energy, Financial, Healthcare, Industrial Goods, Recommended, Technology
Using our large website network of 50+ websites in different industries, we can generate high quality business leads for any marketing campaign in almost any industry. These business leads are high quality because they are searching the web for solutions to their problems/requirements are are ready buyers.
We generate business leads by placing ads (text and/or image) on our website network, and by having a custom page for each campaign, which is used to share initial information and collect the contact info/inquiry from the interest person/lead. Read more
Obama Signs $938 billion Healthcare Bill
The much debated Us Healthcare bill has been passed and signed by President Obama – marking the the biggest shift in U.S. domestic policy since the 1960s.
This bill will extend coverage to 32 million uninsured Americans and ban such insurance company practices as denying coverage to people with medical problems.
The first changes under the overhaul take effect by the end of September. Other changes would not kick in until 2014. By then, most Americans will for the first time be required to carry health insurance — through an employer, through a government program or by buying it for themselves. Those who refuse will face penalties from the IRS.
Tax credits to help pay for premiums also will start flowing to middle-class working families with incomes up to $88,000 a year, and Medicaid will be expanded to cover more low-income people.
The bill is expected to cut the US federal budget deficits by about $143 billion over a decade.
Alpha Neuron – Business & Investment Advisors
Filed under: Assets & Fund Management, Business-Services, Capital Markets, Consumer Goods, E-Business, Energy, Financial, Healthcare, Industrial Goods, Insurance, Internet & New Media, Legal, Outsourcing, Recommended, Retail, Technology, Venture Capital & Private Equity
Alpha Neuron has expertise in Business Planning, Business Valuation, Business Buying and Selling, M&A, Startup Funding and Strategic Equity Investments.
Our work is backed by is a strong base of real-life business challenges and solutions. The quality of your decisions improves with experience, but that also means making mistakes as you go along. With Alpha Neuron’s help in business decision making, you can shave off some mistakes and add them to your list of successful decisions.
To help business owners and managers, we have prepared a few packages to solve specific business problems. For example, to increase sales, cut costs, create JVs, or improve team morale which has a direct bearing on productivity and profitability. Website: AlphaNeuron.com
Free Download link for: Business Decisions Guide by Alpha Neuron
Sinovac Biotech
Filed under: Biotech & Pharma, Health Products & Drugs, Healthcare
Sinovac Biotech is a biopharmaceutical company from China, which through its subsidiaries, engages in the research, development, production, and sale of vaccines that protect against human infectious diseases primarily in China.
Sinovac offers:
- Healive, a vaccine for hepatitis A
- Bilive, a combined hepatitis A and B vaccine, and
- Anflu, a split virus influenza vaccine.
Sinovac also develops:
- vaccines for the H5N1 strain of pandemic influenza virus that are in Phase I and Phase II clinical trials;
- a vaccine for the Japanese encephalitis virus, which is in pre-clinical development stage; and
- a vaccine for the SARS virus that has completed a Phase I clinical trial.
Sinovac Biotech markets and sells its vaccine products primarily through various provincial and municipal centers for disease control. The company was founded in 1999 and is headquartered in Beijing.
Latest News:
Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
Sinovac Announces that Government Investigation Rules Out Healive
Website: www.sinovac.com
Downloads
-